Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study. Fang S, Yarmolinsky J, Gill D, Bull CJ, et al. PLoS Med 2023;20:e1003988.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fang S, Yarmolinsky J, Gill D, Bull CJ, et al. Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study. PLoS Med 2023;20:e1003988.
PMID: 36595504